Highlights: ·       The coronavirus disease-2019 (COVID-19) pandemic had put an enormous burden on the healthcare sector along with distressing socio-economic impact.1 ·       Based on various clinical and preclinical trials results, favipiravir has been approved for its use in mild to moderate COVID-19 patients in India. 2 ·       This article summarizes the use of favipiravir in Indian perspective, results for favipiravir clinical trial in India, and its approval and uses in India.